Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 31 December

Bell Direct
December 31, 2019

Morning Bell 30 December

Bell Direct
December 30, 2019

From the Helm: Michael McCorry

Bell Direct
December 23, 2019

Morning Bell 23 December

Bell Direct
December 23, 2019

Morning Bell 19 December

Bell Direct
December 19, 2019

Morning Bell 18 December

Bell Direct
December 18, 2019

Morning Bell 17 December

Bell Direct
December 17, 2019

Morning Bell 16 December

Bell Direct
December 16, 2019

Morning Bell 12 December

Bell Direct
December 12, 2019

Morning Bell 10 December

Bell Direct
December 10, 2019

Morning Bell 9 December

Bell Direct
December 9, 2019

Weekly Wrap 6th December

Bell Direct
December 6, 2019